OCXOncocyteOCX info
$2.95info-5.14%24h
Global rank29078
Market cap$24.37M
Change 7d-7.52%
YTD Performance14.79%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Oncocyte (OCX) Stock Overview

    OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, biopharma, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

    OCX Stock Information

    Symbol
    OCX
    Address
    15 CushingIrvine, CA 92618United States
    Founded
    -
    Trading hours
    -
    Website
    https://oncocyte.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    949 409 7600

    Oncocyte (OCX) Price Chart

    -
    Value:-

    Oncocyte Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.95
    N/A
    Market Cap
    $24.37M
    N/A
    Shares Outstanding
    8.26M
    N/A
    Employees
    75.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org